287 related articles for article (PubMed ID: 23493549)
1. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
2. Modulation of GDP-fucose level for generating proteins with reduced rate of fucosylation (WO2010141855).
Taupin P
Expert Opin Ther Pat; 2011 Sep; 21(9):1497-9. PubMed ID: 21548846
[TBL] [Abstract][Full Text] [Related]
3. Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc).
Sturla L; Rampal R; Haltiwanger RS; Fruscione F; Etzioni A; Tonetti M
J Biol Chem; 2003 Jul; 278(29):26727-33. PubMed ID: 12738772
[TBL] [Abstract][Full Text] [Related]
4. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
5. Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-Dehydratase.
Allen JG; Mujacic M; Frohn MJ; Pickrell AJ; Kodama P; Bagal D; San Miguel T; Sickmier EA; Osgood S; Swietlow A; Li V; Jordan JB; Kim KW; Rousseau AC; Kim YJ; Caille S; Achmatowicz M; Thiel O; Fotsch CH; Reddy P; McCarter JD
ACS Chem Biol; 2016 Oct; 11(10):2734-2743. PubMed ID: 27434622
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans.
Tsukimura W; Kurogochi M; Mori M; Osumi K; Matsuda A; Takegawa K; Furukawa K; Shirai T
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2353-2359. PubMed ID: 29090617
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
8. Two pathways for importing GDP-fucose into the endoplasmic reticulum lumen function redundantly in the O-fucosylation of Notch in Drosophila.
Ishikawa HO; Ayukawa T; Nakayama M; Higashi S; Kamiyama S; Nishihara S; Aoki K; Ishida N; Sanai Y; Matsuno K
J Biol Chem; 2010 Feb; 285(6):4122-4129. PubMed ID: 19948734
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.
Dai Y; Hartke R; Li C; Yang Q; Liu JO; Wang LX
ACS Chem Biol; 2020 Oct; 15(10):2662-2672. PubMed ID: 32930566
[TBL] [Abstract][Full Text] [Related]
11.
Zhou Q; Xie Y; Lam M; Lebrilla CB
Cells; 2021 Sep; 10(9):. PubMed ID: 34571967
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells.
Ohyama C; Smith PL; Angata K; Fukuda MN; Lowe JB; Fukuda M
J Biol Chem; 1998 Jun; 273(23):14582-7. PubMed ID: 9603974
[TBL] [Abstract][Full Text] [Related]
13. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
14. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality.
Louie S; Haley B; Marshall B; Heidersbach A; Yim M; Brozynski M; Tang D; Lam C; Petryniak B; Shaw D; Shim J; Miller A; Lowe JB; Snedecor B; Misaghi S
Biotechnol Bioeng; 2017 Mar; 114(3):632-644. PubMed ID: 27666939
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated rhamnosides inhibit cellular fucosylation.
Pijnenborg JFA; Rossing E; Merx J; Noga MJ; Titulaer WHC; Eerden N; Veizaj R; White PB; Lefeber DJ; Boltje TJ
Nat Commun; 2021 Dec; 12(1):7024. PubMed ID: 34857733
[TBL] [Abstract][Full Text] [Related]
16. Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC.
Imai-Nishiya H; Mori K; Inoue M; Wakitani M; Iida S; Shitara K; Satoh M
BMC Biotechnol; 2007 Nov; 7():84. PubMed ID: 18047682
[TBL] [Abstract][Full Text] [Related]
17. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
18. Use of 5-Thio-L-Fucose to modulate binding affinity of therapeutic proteins.
Zimmermann M; Nguyen M; Schultheiss CM; Kolmar H; Zimmer A
Biotechnol Bioeng; 2021 May; 118(5):1818-1831. PubMed ID: 33501689
[TBL] [Abstract][Full Text] [Related]
19. Fucosylation in cancer biology and its clinical applications.
Shan M; Yang D; Dou H; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():93-119. PubMed ID: 30905466
[TBL] [Abstract][Full Text] [Related]
20. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis.
Wu ZL; Whittaker M; Ertelt JM; Person AD; Kalabokis V
Glycobiology; 2020 Dec; 30(12):970-980. PubMed ID: 32248235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
